ClinicalTrials.govpublic full text
A First Time in Human (FTIH) Study of GSK3745417 Administered to Participants With Advanced Solid Tumors
neoplasms, gsk3745417, dostarlimab, anti-programmed death receptor-1 (pd-1), monoclonal antibody, solid tumor, first time in human, stimulator of interferon genes, sting, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 800662
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.